We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia.

1. You are allergic to somatrogon, or any of the ingredients listed at the end of this leaflet. Symptoms of an allergic reaction may include chest tightness, shortness of breath, wheezing or difficulty breathing, swelling of the face, lips, tongue, throat or other parts of the body, hives, itching or severe skin rash. Always check the ingredients to make sure you can use this medicine.

2. You have an active tumour or evidence of cancer growth or are currently being treated for cancer.

3. You have a serious illness following open heart or stomach surgery, or due to multiple injuries or respiratory failure (your lungs can't get enough oxygen into your blood).

As part of our SLAS Europe 2022 coverage, we speak to Dr. Javier Terriente, Co-founder and Chief of Drug Development at ZeClinics, about how zebrafish could be the future for discovering new therapeutics.

In this interview, News-Medical talks to Adrienne Sherk about how Unite Us has created an efficient system of care within communities to improve health.

As part of our SLAS Europe 2022 coverage, we speak to Ian Shuttler from Tecan about their new MagicPrepTM NGS technology.

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

This site complies with the HONcode standard for trustworthy health information: verify here.

News-Medical.net - An AZoNetwork Site

Owned and operated by AZoNetwork, © 2000-2022